Africa (WHO region) vs Syria: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Syria
100.0%
in 2021
Africa (WHO region) rank
2nd
Syria rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Syria
How they compare
Syria currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
Across all 11 years both countries report, Syria has been ahead every year.
Africa (WHO region) ranks 2nd and Syria ranks 1st of 11 groups.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 100.0% | 70.0% | Syria |
| 2010s | 77.6% | 100.0% | 22.4% | Syria |
| 2020s | 91.5% | 100.0% | 8.5% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Syria?
- Syria, at 100.0% against 96.0% in Africa (WHO region) as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Syria?
- 4.0%, with Syria ahead.
- How many years of comparable data are there for Africa (WHO region) and Syria?
- 11 years are reported by both, from 2007 to 2021.
- How do Africa (WHO region) and Syria rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Syria ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.